These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 21087567)

  • 41. [Protein-losing enteropathy following Fontan operation for a complex heart defect].
    Galal O; Kersten J; Götze H; Stoermer J
    Monatsschr Kinderheilkd; 1984 Nov; 132(11):870-2. PubMed ID: 6513949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
    Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Atrial natriuretic peptide: could it be a marker for postoperative recurrent effusions after Fontan circulation in complex congenital heart defects?
    Alkan T; Sarioğlu A; Samanli UB; Sarioğlu T; Akçevin A; Türkoğlu H; Paker T; Aytaç A
    ASAIO J; 2006; 52(5):543-8. PubMed ID: 16966855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of iron deficiency in protein-losing enteropathy following the Fontan procedure.
    Yetman AT; Everitt MD
    Congenit Heart Dis; 2011; 6(4):370-3. PubMed ID: 21392262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decompression of the thoracic duct: A novel transcatheter approach.
    Smith CL; Hoffman TM; Dori Y; Rome JJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E56-E61. PubMed ID: 31444883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of the modified Fontan procedure are not related to age at operation.
    Pace Napoleone C; Oppido G; Angeli E; Giardini A; Resciniti E; Gargiulo G
    Eur J Cardiothorac Surg; 2010 Mar; 37(3):645-50. PubMed ID: 19800250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single ventricle palliation: greater risk of complications with the Fontan procedure than with the bidirectional Glenn procedure alone.
    Day RW; Etheridge SP; Veasy LG; Jenson CB; Hillman ND; Di Russo GB; Thorne JK; Doty DB; McGough EC; Hawkins JA
    Int J Cardiol; 2006 Jan; 106(2):201-10. PubMed ID: 16321693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fontan conversion with hepatic vein exclusion: a means for hepatic preservation in single ventricle heart disease.
    Kogon B; McConnell M; Book W
    Cardiol Young; 2016 Mar; 26(3):582-5. PubMed ID: 26139025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver and cardiac function in the long term after Fontan operation.
    Camposilvan S; Milanesi O; Stellin G; Pettenazzo A; Zancan L; D'Antiga L
    Ann Thorac Surg; 2008 Jul; 86(1):177-82. PubMed ID: 18573420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein-losing enteropathy and plastic bronchitis after the Fontan procedure.
    Sharma VJ; Iyengar AJ; Zannino D; Gentles T; Justo R; Celermajer DS; Bullock A; Winlaw D; Wheaton G; Burchill L; Cordina R; d'Udekem Y
    J Thorac Cardiovasc Surg; 2021 Jun; 161(6):2158-2165.e4. PubMed ID: 32928546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term problems after cavopulmonary anastomosis: diagnosis and management.
    Hess J
    Thorac Cardiovasc Surg; 2001 Apr; 49(2):98-100. PubMed ID: 11339460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Volume load paradox while preparing for the Fontan: not too much for the ventricle, not too little for the lungs.
    Gewillig M; Brown SC; Heying R; Eyskens B; Ganame J; Boshoff DE; Budts W; Gorenflo M
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):262-5. PubMed ID: 19945986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subdiaphragmatic venous hemodynamics in patients with biventricular and Fontan circulation after diaphragm plication.
    Hsia TY; Khambadkone S; Bradley SM; de Leval MR
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1397-405; discussion 1405. PubMed ID: 18023650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Lymphatic System in the Fontan Patient-Pathophysiology, Imaging, and Interventions: What the Anesthesiologist Should Know.
    RochéRodríguez M; DiNardo JA
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt A):2669-2678. PubMed ID: 34446325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases.
    Lin WS; Hwang MS; Chung HT; Chu JJ; Lai MW; Yang JS; Huang SC; Huang JL; Su WJ
    Chang Gung Med J; 2006; 29(5):505-12. PubMed ID: 17214396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcome of 193 extracardiac Fontan patients: the first 15 years.
    Giannico S; Hammad F; Amodeo A; Michielon G; Drago F; Turchetta A; Di Donato R; Sanders SP
    J Am Coll Cardiol; 2006 May; 47(10):2065-73. PubMed ID: 16697327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation.
    Turner Z; Lanford L; Webber S
    Congenit Heart Dis; 2012; 7(1):24-30. PubMed ID: 22129195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protein-losing enteropathy after the Fontan operation.
    Feldt RH; Driscoll DJ; Offord KP; Cha RH; Perrault J; Schaff HV; Puga FJ; Danielson GK
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):672-80. PubMed ID: 8800155
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term results after Fontan procedure and its modifications.
    de Vivie ER; Rupprath G
    J Thorac Cardiovasc Surg; 1986 May; 91(5):690-7. PubMed ID: 3702478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results of transcatheter Fontan fenestration to treat protein losing enteropathy.
    Vyas H; Driscoll DJ; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2007 Mar; 69(4):584-9. PubMed ID: 17323361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.